AngioDynamics | ANGO - Sales Revenues

Stock Price
10.81
Daily Change
-0.18 -1.64%
Monthly
2.37%
Yearly
14.88%
Q1 Forecast
11.09

AngioDynamics reported $72M in Sales Revenues for its fiscal quarter ending in February of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 72M 841K Feb/2025
Artivion USD 95.78M 2.24M Sep/2024
AtriCure USD 140.5M 6.2M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
ICU Medical USD 540.7M 3.7M Dec/2025
Inogen USD 74.93M 504K Sep/2024
J&J USD 24.6B 610M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 799.49M 602.88M Dec/2024
Smiths GBP 1.31B 301M Dec/2025
Surmodics USD 29.92M 96.16M Dec/2024
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025